Related Experiment Videos
Neurotoxicity secondary to antineoplastic drugs
1Department of Oncology, Herlev University Hospital, Denmark.
Cancer Treatment Reviews
|April 1, 1994
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
Gemcitabine and Cisplatin Versus Methotrexate, Vinblastine, Doxorubicin, and Cisplatin in Advanced or Metastatic Bladder Cancer: Results of a Large, Randomized, Multinational, Multicenter, Phase III Study.
Journal of clinical oncology : official journal of the American Society of Clinical Oncology·2023
A randomised study of tailored toxicity-based dosage of fluorouracil-epirubicin-cyclophosphamide chemotherapy for early breast cancer (SBG 2000-1).
European journal of cancer (Oxford, England : 1990)·2018
Effect of environmental stress and immobilization on stress physiological variables in farmed mink.
Behavioural processes·2014
The effects of feed restriction on physical activity, body weight, physiology, haematology and immunology in female mink.
Research in veterinary science·2011
CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use.
International journal of gynecological cancer : official journal of the International Gynecological Cancer Society·2005
Chondrosarcoma: A comprehensive review of tumor biology, clinical behavior, and therapeutic advances.
Cancer treatment reviews·2026
Pharmacological prevention of second primary cancers: From chemoprevention to precision cancer interception.
Cancer treatment reviews·2026
Understanding extrapulmonary neuroendocrine carcinomas: Survival, prognosis, and patient quality of life.
Cancer treatment reviews·2026
Identification of a novel small-molecule modulator targeting SNX10 to inhibit osteoclastic bone resorption.
Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research·2026
Recurrence distance analysis for clinical target volume optimization in glioblastoma.
Clinical and translational radiation oncology·2026